Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Updated: May 12, 2026
Jim Birchenough's Stock Ratings
Wells Fargo Analyst
Jim Birchenough is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
38.8%
Smart Score
Overall Average Return Percentile
89th
Number of Ratings
43
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/31/2024 | SGMO | Buy Now | Sangamo Therapeutics | $0.12 | 1552.89% | $3 → $2 | Maintains | Equal-Weight | Get Alert | |
| 03/13/2024 | RGLS | Buy Now | Regulus Therapeutics | — | — | $2 → $3 | Maintains | Equal-Weight | Get Alert | |
| 02/22/2024 | CRSP | Buy Now | CRISPR Therapeutics | $54.80 | 27.74% | $55 → $70 | Maintains | Equal-Weight | Get Alert | |
| 11/06/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.12 | 726.45% | → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 08/09/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | $66 → $68.5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/25/2022 | MEIP | Buy Now | MEI Pharma | — | — | $13 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 02/10/2022 | TPTX | Buy Now | Turning Point | — | — | $120 → $85 | Maintains | Overweight | Get Alert | |
| 02/09/2022 | ZYME | Buy Now | Zymeworks | $24.03 | 99.75% | $56 → $48 | Maintains | Overweight | Get Alert | |
| 09/22/2021 | ADAP | Buy Now | Adaptimmune Therapeutics | — | — | $6 → $7 | Maintains | Equal-Weight | Get Alert | |
| 07/28/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $4 → $14 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 03/17/2021 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $2 → $4 | Maintains | Equal-Weight | Get Alert | |
| 03/04/2021 | FATE | Buy Now | Fate Therapeutics | $2.17 | 5879.76% | $84 → $130 | Maintains | Overweight | Get Alert | |
| 02/22/2021 | PGEN | Buy Now | Precigen | $4.22 | 231.75% | → $14 | Initiates | → Overweight | Get Alert | |
| 02/02/2021 | GRCL | Buy Now | Gracell Biotechnologies | — | — | — | Initiates | → Overweight | Get Alert | |
| 02/01/2021 | MRNA | Buy Now | Moderna | $53.15 | 172.81% | $129 → $145 | Maintains | Equal-Weight | Get Alert | |
| 12/07/2020 | CRSP | Buy Now | CRISPR Therapeutics | $54.80 | 164.6% | → $145 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 11/23/2020 | MRNA | Buy Now | Moderna | $53.15 | 73.1% | → $92 | Initiates | → Equal-Weight | Get Alert | |
| 11/11/2020 | FPRX | Buy Now | Five Prime Therapeutics | — | — | → $34 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 10/30/2020 | BLCM | Buy Now | Bellicum Pharmaceuticals | — | — | → $4.5 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 10/29/2020 | GILD | Buy Now | Gilead Sciences | $133.20 | -52.7% | $69 → $63 | Maintains | Equal-Weight | Get Alert | |
| 09/14/2020 | IMMU | Buy Now | Immunomedics | — | — | — | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 07/07/2020 | RNA | Buy Now | Avidity Biosciences | $13.08 | — | — | Initiates | → Overweight | Get Alert | |
| 06/29/2020 | ICPT | Buy Now | Intercept Pharma | — | — | $146 → $46 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 06/25/2020 | QURE | Buy Now | uniQure | $27.54 | 103.34% | → $56 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 05/26/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $712.77 | 2.98% | → $734 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/18/2020 | IMV | Buy Now | IMV | — | — | $2.5 → $8.5 | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 05/13/2020 | TPTX | Buy Now | Turning Point | — | — | $62 → $76 | Maintains | Overweight | Get Alert | |
| 05/12/2020 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $1.5 → $1 | Maintains | Equal-Weight | Get Alert | |
| 04/23/2020 | IMMU | Buy Now | Immunomedics | — | — | $34 → $41 | Maintains | Overweight | Get Alert | |
| 04/20/2020 | GILD | Buy Now | Gilead Sciences | $133.20 | -34.68% | → $87 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 04/06/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $712.77 | -38.97% | $370 → $435 | Maintains | Equal-Weight | Get Alert | |
| 03/26/2020 | CYAD | Buy Now | Celyad Oncology | — | — | $44 → $20 | Maintains | Overweight | Get Alert | |
| 03/13/2020 | KZR | Buy Now | Kezar Life Sciences | $7.37 | 144.23% | $30 → $18 | Maintains | Overweight | Get Alert | |
| 03/11/2020 | SNSS | Buy Now | Sunesis Pharmaceuticals | — | — | $3 → $1 | Downgrade | Overweight → Equal-Weight | Get Alert | |
| 03/04/2020 | INFI | Buy Now | Infinity Pharmaceuticals | — | — | $2.5 → $1.5 | Maintains | Equal-Weight | Get Alert | |
| 01/21/2020 | IMV | Buy Now | IMV | — | — | — | Upgrade | Equal-Weight → Overweight | Get Alert | |
| 01/15/2020 | ZYME | Buy Now | Zymeworks | $24.03 | 141.36% | $48 → $58 | Maintains | Overweight | Get Alert | |
| 12/17/2019 | ICPT | Buy Now | Intercept Pharma | — | — | $120 → $146 | Maintains | Overweight | Get Alert | |
| 12/09/2019 | FATE | Buy Now | Fate Therapeutics | $2.17 | 1003.96% | → $24 | Upgrade | Market Perform → Outperform | Get Alert | |
| 11/06/2019 | FATE | Buy Now | Fate Therapeutics | $2.17 | 635.97% | $24 → $16 | Downgrade | Outperform → Market Perform | Get Alert | |
| 10/07/2019 | AKCA | Buy Now | Akcea Therapeutics | — | — | — | Upgrade | Market Perform → Outperform | Get Alert | |
| 09/30/2019 | IMMU | Buy Now | Immunomedics | — | — | $14 → $16 | Maintains | Market Perform | Get Alert | |
| 09/04/2019 | TPTX | Buy Now | Turning Point | — | — | $53 → $62 | Maintains | Outperform | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved